The full content of Annals is available to subscribers

Subscribe/Learn More  >
Diagnosis and Treatment |


Ann Intern Med. 1973;79(6):844-847. doi:10.7326/0003-4819-79-6-844
Text Size: A A A

Carbamazepine was approved 5 years ago by the FDA for treatment of pain associated with trigeminal neuralgia and glossopharyngeal neuralgia. It is now the principal drug for treatment of these conditions. Studies have shown that it is also effective in the treatment of the lightning pains associated with tabes dorsalis; however, it was not approved by the FDA for this condition. Carbamazepine is used most of the world outside the United States as an anticonvulsant. Currently, controlled studies in the United States are under way to determine its efficacy in treating seizure disorders. Because carbamazepine has many side reactions, completely listed in the package insert, patients receiving this drug must be followed closely.







Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.